Overview

Concomitant Versus Hybrid Regimen for H. Pylori Eradication

Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
10 day concomitant versus 14 day hybrid regimen as first line H. pylori eradication treatment in a high clarithromycin resistance area. A multicenter, randomized, equivalence trial.
Phase:
Phase 4
Details
Lead Sponsor:
Alexandra Hospital, Athens, Greece
Collaborator:
Hellenic Society of Gastroenterology
Treatments:
Amoxicillin
Clarithromycin
Esomeprazole
Metronidazole